Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolin Bloch

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|May 29, 2014
SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitorsAndrew D Huber, Eleftherios Michailidis, Megan L Schultz, et al.
Nature Immunology|February 14, 2012
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesHichem Lahouassa, Waaqo Daddacha, Henning Hofmann, et al.
Glycobiology|June 21, 2023
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement bindingSarah Y Ebstein, Ashique Rafique, Yi Zhou, et al.
Cell Reports. Medicine|September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapiesJiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Antimicrobial Agents and Chemotherapy|May 29, 2014
SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitorsAndrew D Huber, Eleftherios Michailidis, Megan L Schultz, et al.
Nature Immunology|February 14, 2012
SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphatesHichem Lahouassa, Waaqo Daddacha, Henning Hofmann, et al.
Glycobiology|June 21, 2023
VSIG4 interaction with heparan sulfates inhibits VSIG4-complement bindingSarah Y Ebstein, Ashique Rafique, Yi Zhou, et al.
Cell Reports. Medicine|September 26, 2024
A PD-1-targeted, receptor-masked IL-2 immunocytokine that engages IL-2Rα strengthens T cell-mediated anti-tumor therapiesJiaxi Wu, Nicolin Bloch, Aaron Y Chang, et al.
Pageof 2